Literature DB >> 8061422

Contrast media for MR imaging of the heart.

M Saeed1, M F Wendland, C B Higgins.   

Abstract

The role of contrast media for quantitative characterization of ischemic myocardial events with magnetic resonance (MR) imaging has advanced considerably in the past few years. Contrast material-enhanced MR imaging is useful for identifying and sizing myocardial infarcts and for distinguishing between occlusive and reperfused myocardial infarcts. Recent results suggest that contrast-enhanced MR imaging can also be used to identify areas of cell death in regions of reperfused myocardial infarction. With the aid of MR contrast media, fast MR imaging techniques may be useful in estimating regional myocardial perfusion. Although no simple relationship between signal intensity and concentration exists, contrast-enhanced MR perfusion imaging can demonstrate the presence and relative severity of hypoperfused myocardium. Combining myocardial perfusion imaging with the anatomic and functional information provided by other MR imaging techniques could make MR imaging a comprehensive noninvasive means of evaluating ischemic cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061422     DOI: 10.1002/jmri.1880040310

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

Review 1.  Cardiac MRI for assessment of myocardial perfusion: current status and future perspectives.

Authors:  T Laddis; W J Manning; P G Danias
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 2.  Ultra-high-speed MR imaging.

Authors:  C P Davis; G C McKinnon; J F Debatin; G K von Schulthess
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 3.  Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.

Authors:  Alfonso H Waller; Ron Blankstein; Raymond Y Kwong; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.